Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The American Journal of Tropical Medicine and Hygiene|January 8, 2025
Identification of Anthrax as the Cause of a Cluster of Unexplained Deaths, Uganda, 2023: The Role of Metagenomic Next-Generation Sequencing and Postmortem SpecimensNicholas Bbosa, Deogratius Ssemwanga, Sonja L Weiss, et al.Microorganisms|December 31, 2025
teamNGS Balances Sensitivity for Viruses with Comprehensive Microbial Detection in Clinical SpecimensJulie Yamaguchi, Gregory S Orf, Jenna Malinauskas, et al.Biotechniques|August 25, 2022
Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic testsBryan C Tieman, Stephen Kovacs, Mary A Rodgers, et al.JCI Insight|May 20, 2025
Metagenomic detection of central nervous system infections missed by conventional testingNoely Evangelista Ferreira, Michael G Berg, Antonio C da Costa, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 27, 2022
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological testsMary A Rodgers, Ana Olivo, Barbara J Harris, et al.Frontiers in Microbiology|August 15, 2022
A SARS-CoV-2 Negative Antigen Rapid Diagnostic in RT-qPCR Positive Samples Correlates With a Low Likelihood of Infectious Viruses in the NasopharynxIsadora Alonso Corrêa, Débora Souza Faffe, Rafael Mello Galliez, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 2, 2025
Robust mission-driven responses to infectious disease threats delivered by the Abbott pandemic defense coalitionMary A Rodgers, Francisco Averhoff, Michael G Berg, et al.Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.Science Advances|July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.Pageof 6